Jerusalem Pharmaceuticals Co. Ltd.

JPH

PS2016112695

Pharmaceuticals

End-of-day quote Palestine Exchange Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
3.81 ^USD	-.--%		-.--%	+0.26%

2023	Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Jerusalem Pharmaceuticals Co. Ltd. Approves Dividend for the Year 2018, Payable on 21 June 2019

April 21, 2019

Jerusalem Pharmaceuticals Co. Ltd. approved dividend for the year 2018. Dividend is payable on 21 June 2019, record date is 23 April 2019. Cash distribution value is 1800000.000 and cash distribution ratio is 10.0.

Latest news about Jerusalem Pharmaceuticals Co. Ltd.

Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Dec. 06	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-13	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-09	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-14	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-14	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-31	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-15	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-05-09	CI
Jerusalem Pharmaceuticals Co. Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2019	19-04-29	CI
Jerusalem Pharmaceuticals Co. Ltd. Approves Dividend for the Year 2018, Payable on 21 June 2019	19-04-21	CI
Jerusalem Pharmaceuticals Co. Ltd. Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2018	19-03-30	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Consolidated Unaudited Earnings Results for the Year Ended December 31, 2018	19-02-16	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Unaudited Earnings Results for the Nine Months Ended September 30, 2018	18-10-31	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Consolidated Earnings Results for the First Half of 2018	18-08-30	CI
Jerusalem Pharmaceuticals Co. Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2018	18-04-28	CI
Jerusalem Pharmaceuticals Co. Ltd. Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2017	18-03-30	CI
Jerusalem Pharmaceuticals Co. Ltd. Announces Unaudited Earnings Results for the Full Year Ended December 31, 2017	18-02-14	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Unaudited Consolidated Earnings Results for the Nine Months Ended September 30, 2014	14-10-28	CI
Jerusalem Pharmaceuticals Company Reports Audited Consolidated Earnings Results for the Year 2013	14-03-30	CI
Jerusalem Pharmaceuticals Co. Announces Unaudited Consolidated Preliminary Financial Results for Year Ended December 31, 2013	14-02-12	CI

Chart Jerusalem Pharmaceuticals Co. Ltd.

Duration

Period

Chart Jerusalem Pharmaceuticals Co. Ltd.

More charts

Company Profile

Jerusalem Pharmaceuticals Co Ltd (Al-Quds) is a Palestine-based public shareholding company engaged in the manufacture and trade of pharmaceutical, veterinary, detergent, and cosmetics products. Its product range spans the whole spectrum of ethical pharmaceuticals, as well as over the counter preparations and nutritional supplements. Its Products are presented in different dosage forms such as tablets, capsules, ampoules, granules and powders for suspensions, suspensions, syrups, lotions, powders, suppositories, ovules, creams, ointments, gels, emulgels, ear, eye and nose drops, solutions, mouth rinse and gargles. The Company also produces veterinary products including vials, powders, oral liquids and fodder additives such as multivitamins and multi-minerals. It also manufactures detergents and cosmetics under license from French companies. The Company operates three production facilities include Factory for General Production, Penicillin Factory and Cephalosporin Factory.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
JERUSALEM PHARMACEUTICALS CO. LTD.	+0.26%	68.58M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.61%	43.18B
OTSUKA HOLDINGS CO., LTD.	+20.67%	22.59B
SANDOZ GROUP AG	+14.56%	14.56B
CIPLA LIMITED	+13.94%	13.54B
ZYDUS LIFESCIENCES LIMITED	+43.35%	11.5B
ONO PHARMACEUTICAL CO., LTD.	-8.37%	6.93B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+10.21%	5.36B